This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Opexa Therapeutics Inc
OPXA : NASDAQ : Health Care
$1.04 0.06 | 6.13%
Today's Range: 1.00 - 1.05
Avg. Daily Volume: 206,600
10/22/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
OPXA OPEXA THERAPEUTICS INC 0.87 24.24 n/m 1.36 138.13
ENZN ENZON PHARMACEUTICALS INC 0.96 42.36 1.60 33.00 -17.53
APPY VENAXIS INC 1.31 40.60 n/m 0.20 194.11
CYTX CYTORI THERAPEUTICS INC 0.51 40.57 n/m 8.90 -39.36
OGEN ORAGENICS INC 0.96 34.73 n/m 1.21 16.07
GNVC GENVEC INC 1.71 29.53 n/m 3.99 -28.86
RXII RXI PHARMACEUTICALS CORP 1.80 28.99 n/m 0.16 -56.80
CBLI CLEVELAND BIOLABS INC 0.40 22.84 n/m 7.40 38.10
XTLB XTL BIOPHARMACEUTICALS 1.71 20.28 n/m 2.15 1.31
DARA DARA BIOSCIENCES INC 0.85 16.58 n/m 0.89 486.84
ICCC IMMUCELL CORP 4.85 14.68 n/m 6.42 12.32
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

OPXA Ind Avg S&P 500
n/m 79.53 18.06
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs